Alaunos Therapeutics Inc.

TCRT | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.27

+$0.01 (+0.79%)

Sep 22, 2026, 12:38 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	1.39M	1.09M	6.06M	39.06M	76.05M	115.07M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	887K	n/a	n/a	542K	673K	875K
Receivables	3K	5K	1K	4K	1.11M	4.67M
Inventory	n/a	n/a	n/a	13.94M	n/a	n/a
Other Current Assets	600K	1.66M	2.2M	799K	1.67M	n/a
Total Current Assets	1.99M	2.76M	8.26M	53.8M	78.83M	130.59M
Property-Plant & Equipment	91K	n/a	2K	10.6M	15.36M	14.88M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	978K	n/a	2K	11.14M	16.03M	15.76M
Total Assets	2.97M	2.76M	8.26M	64.94M	94.87M	146.35M
Account Payables	613K	516K	616K	1.39M	1.37M	960K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	17.32M	8.6M	n/a
Other Current Liabilities	n/a	n/a	1.3M	3.74M	3.65M	13.28M
Total Current Liabilities	813K	692K	1.96M	24.17M	16.04M	18.37M
Long-Term Debt	n/a	n/a	n/a	n/a	16.25M	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	28K	-1K	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	2.22M	20.77M	4M
Total Liabilities	813K	692K	1.96M	26.38M	36.81M	22.36M
Total Debt	n/a	n/a	n/a	20.07M	30.09M	4.81M
Book Value	2.15M	2.06M	6.31M	38.56M	58.06M	123.98M
Book Value Per Share	1.11	1.29	3.94	26.63	40.62	88.71
Common Stock	2K	2K	16K	240K	216K	215K
Retained Earnings	-924.62M	-920.45M	-915.77M	-880.63M	-842.85M	-764.1M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	2.15M	2.06M	6.31M	38.56M	58.06M	123.98M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a